Endocrinologist; Director of Clinical Diabetes, the Baker Heart and Diabetes Institute, Melbourne
Neale Cohen is currently the Director of Clinical Diabetes at the Baker Heart and Diabetes Institute in Melbourne. He is an endocrinologist in clinical practice for over 20 years at the International Diabetes Institute and now the Baker. In his current position he is responsible for the management of one of the largest diabetes outpatient service in Australia, including two Melbourne based services, an outreach service in Central Australia and a Telehealth service in regional Victoria. His clinical research interests include indigenous diabetes, Type 2 diabetes therapeutics, and technology in Type 1 diabetes. He has currently appointments as Associate Professor at University of Queensland and Monash University
He graduated from Monash University in 1984 doing post graduate training at the Alfred Hospital, the International Diabetes Institute and the Austin Hospital and attained his specialty status in endocrinology in 1992
In this era of SGLT2 inhibitors and GLP1 agonists, we need to initiate these therapies early because of their cardioprotective and renoprotective (for SGLT2I) benefits
Genetic factors make lifestyle changes less effective and some are at risk of a form of malignant, rapidly progressive T2DM in the setting of severe insulin resistance
Genetic factors make lifestyle changes less effective and some are at risk of a form of malignant, rapidly progressive T2DM in the setting of severe insulin resistance
In this era of SGLT2 inhibitors and GLP1 agonists, we need to initiate these therapies early because of their cardioprotective and renoprotective (for SGLT2I) benefits
Save 50% on all seminars. Hurry, sale ends Dec 31!
You're invited to attend the Women's & Children's Health Update 2026, Australia's most popular seminar for GPs and healthcare professionals. Secure your seat by midnight Dec 31 and save!